Active pharmaceutical ingredient concurrent validation allowed in draft GMP guidance.
API CONCURRENT VALIDATION PERMITTED IN FDA DRAFT GMP GUIDANCE recently released by the agency. The most recent draft of FDA's guidance, "Manufacturing, Processing or Holding Active Pharmaceutical Ingredients," permits concurrent validation for APIs involved in clinical trials. The document is available on FDA's Web site (www.fda.gov). Written comments will be accepted by the agency through May 18.
More from Archive
More from Pink Sheet
A European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials.
The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.